Microfluidics-free single-cell genomics with templated emulsification

Author:

Clark Iain C.ORCID,Fontanez Kristina M.ORCID,Meltzer Robert H.,Xue Yi,Hayford Corey,May-Zhang AaronORCID,D’Amato Chris,Osman Ahmad,Zhang Jesse Q.,Hettige Pabodha,Ishibashi Jacob S. A.ORCID,Delley Cyrille L.,Weisgerber Daniel W.,Replogle Joseph M.ORCID,Jost Marco,Phong Kiet T.,Kennedy Vanessa E.,Peretz Cheryl A. C.,Kim Esther A.,Song Siyou,Karlon William,Weissman Jonathan S.ORCID,Smith Catherine C.,Gartner Zev J.,Abate Adam R.ORCID

Abstract

AbstractCurrent single-cell RNA-sequencing approaches have limitations that stem from the microfluidic devices or fluid handling steps required for sample processing. We develop a method that does not require specialized microfluidic devices, expertise or hardware. Our approach is based on particle-templated emulsification, which allows single-cell encapsulation and barcoding of cDNA in uniform droplet emulsions with only a vortexer. Particle-templated instant partition sequencing (PIP-seq) accommodates a wide range of emulsification formats, including microwell plates and large-volume conical tubes, enabling thousands of samples or millions of cells to be processed in minutes. We demonstrate that PIP-seq produces high-purity transcriptomes in mouse–human mixing studies, is compatible with multiomics measurements and can accurately characterize cell types in human breast tissue compared to a commercial microfluidic platform. Single-cell transcriptional profiling of mixed phenotype acute leukemia using PIP-seq reveals the emergence of heterogeneity within chemotherapy-resistant cell subsets that were hidden by standard immunophenotyping. PIP-seq is a simple, flexible and scalable next-generation workflow that extends single-cell sequencing to new applications.

Funder

U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health

Howard Hughes Medical Institute

Damon Runyon Cancer Research Foundation

American Cancer Society

Leukemia and Lymphoma Society

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3